GUARDANT HEALTH, INC. (GH) Operating Margin
- Operating margin · 12 months: Value -39.75%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -39.75% | Operating income / revenue. Period ending 2026-06-30. $-470.26M ÷ $1.18B × 100 ≈ -39.75% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -470.26M USD | Operating Income (Loss) |
| Revenue | 1.18B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 413.95M USD | Cost of Goods and Services Sold |
| Research and development | 375.79M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-470.26M | $1.18B | $413.95M | $375.79M | (m) | -39.75% |
| 2026-03-31 | $-447.56M | $1.08B | $379.20M | $366.71M | (m) | -41.43% |
| 2025-12-31 | $-437.25M | $982.02M | $349.01M | $364.19M | (m) | -44.53% |
| 2025-09-30 | $-442.41M | $902.57M | (m) | $359.47M | (m) | -49.02% |
| 2025-06-30 | $-460.75M | $828.85M | (m) | $356.82M | (m) | -55.59% |
| 2025-03-31 | $-454.95M | $774.00M | (m) | $352.47M | (m) | -58.78% |
| 2024-12-31 | $-443.59M | $739.02M | (m) | $347.75M | (m) | -60.02% |
| 2024-09-30 | $-515.14M | $692.26M | (m) | $344.07M | (m) | -74.41% |
| 2024-06-30 | $-511.36M | $643.81M | (m) | $350.61M | (m) | -79.43% |
| 2024-03-31 | $-530.35M | $603.73M | (m) | $357.87M | (m) | -87.85% |
| 2023-12-31 | $-564.73M | $563.95M | (m) | $367.19M | (m) | -100.14% |
| 2023-09-30 | $-513.33M | $535.78M | (m) | $383.92M | (m) | -95.81% |
| 2023-06-30 | $-544.39M | $510.16M | (m) | $390.08M | (m) | -106.71% |
| 2023-03-31 | $-555.10M | $482.15M | (m) | $385.18M | (m) | -115.13% |
| 2022-12-31 | $-544.38M | $449.54M | (m) | $373.81M | (m) | -121.10% |
| 2022-09-30 | $-496.47M | $430.75M | (m) | $340.25M | (m) | -115.26% |
| 2022-06-30 | $-459.15M | $408.13M | (m) | $311.20M | (m) | -112.50% |
| 2022-03-31 | $-426.48M | $391.09M | (m) | $289.47M | (m) | -109.05% |
| 2021-12-31 | $-411.00M | $373.65M | (m) | $263.22M | (m) | -110.00% |
| 2021-09-30 | $-403.96M | $343.86M | (m) | $230.48M | (m) | -117.48% |
| 2021-06-30 | $-370.92M | $323.65M | (m) | $195.76M | (m) | -114.61% |
| 2021-03-31 | $-327.90M | $297.88M | (m) | $168.35M | (m) | -110.08% |
| 2020-12-31 | $-254.95M | $286.73M | (m) | $149.86M | (m) | -88.92% |
| 2020-09-30 | $-189.75M | $271.31M | (m) | $135.46M | (m) | -69.94% |
| 2020-06-30 | $-132.97M | $257.59M | (m) | $123.78M | (m) | -51.62% |
| 2020-03-31 | $-93.62M | $245.23M | (m) | $106.99M | (m) | -38.18% |
| 2019-12-31 | $-82.37M | $214.38M | (m) | $86.29M | (m) | -38.42% |
| 2019-09-30 | $-83.80M | $184.35M | (m) | $77.07M | (m) | -45.45% |
| 2019-06-30 | $-90.52M | $145.19M | (m) | $66.75M | (m) | -62.35% |
| 2019-03-31 | $-97.96M | $110.60M | (m) | $58.77M | (m) | -88.57% |
| 2018-12-31 | $-92.94M | $90.64M | (m) | $50.71M | (m) | -102.54% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-76.61M | $49.84M | (m) | $25.56M | (m) | -153.71% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-43.85M | $25.25M | (m) | $10.86M | (m) | -173.66% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |